Yan Tan1,2, Wei Mu3, Xiaochun Wang1,2, Guoqiang Yang1,2, Robert James Gillies3, and Hui Zhang1,2
1Department of Radiology, First Hospital of Shanxi Medical University, Taiyuan, China, 2College of Medical Imaging, Shanxi Medical University, Taiyuan, China, 3Department of Cancer Physiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States
Synopsis
Assessment of glioma
genotypes by quantifying MR diffusion imaging heterogeneity of whole tumour may
serve as a powerful tool to instruct therapeutic decision-making. This study
evaluated the role and incremental value of whole-tumor radiomics analysis based
on DKI and DTI images in determining the IDH and MGMTmet genotypes of
astrocytomas. A radiomics models based on whole-tumor MK and MD maps showed
good diagnostic efficiency in predicting IDH and MGMTmet genotypes.
Furthermore, the combined model constructed by radiomics score, edema degree
and age further improved the performance of predicting IDH, while the combined
model did not benefit for MGMTmet prediction.
Background and Purpose
Diffusion tensor imaging (DTI) and diffusion
kurtosis imaging (DKI) can probe the pathological changes in gliomas, providing
abundant important information.1 Radiomics allow for more precise diagnosis,
prediction of survival, and assessment of therapeutic response in glioma than
traditional imaging biomarkers, which can thus offer a complementary tool to
existing radiological practice.2-4 Tumors are heterogeneous both genetically
and histopathologically, with intratumoural spatial variation in the
cellularity, angiogenesis, areas of necrosis and extravascular extra-cellular
matrix, which might result in the diffusion heterogeneity of whole tumour.5 Thus,
we postulated that the heterogeneity of DKI and DTI parameter values within
whole gliomas could be useful for predicting IDH and MGMTmet genotypes.
Therefore, this study evaluated the role and incremental value of whole-tumor
radiomics analysis based on DKI and DTI images in determining the IDH and
MGMTmet genotypes of astrocytomas.Method
Sixty-two
patients with astrocytoma (33 males and 29 females) were enrolled. Tumors were
graded using the World Health Organization Classification of Tumors of the
Nervous System (2016) criteria. The clinical characteristics of gender, age and
grade were also studied. IDH status of the patients was determined using Sanger
sequencing, the MGMTmet was determined by pyrosequencing analysis.
Preoperative
MRI was performed with a 3.0-T scanner using an 8-channel array coil. The
scanning sequences included conventional MRI sequences, DKI and DTI sequences.
Echo planar imaging (EPI) sequence was used to perform DTI and DKI. Implemented
b values were 0, 1000, and 2000 mm2/s for DKI (including DTI). These were
applied in 30 uniformly distributed directions. Parameters for DKI data: TR/TE:
6500/11 ms; FOV, 240 mm × 240 mm; matrix, 96 × 96. Slice thickness, 6 mm; slice
interval, 1 mm.
Quantitative
semantic radiological characteristics were assessed, which included tumour
size, border, hemorrhage, cystic and necrosis, edema degree, enhancement style
and degree, signal characteristics, tumour location, cross midline growth,
involving deep white matter, involving pia mater, involving ependymal membrane.
364
radiomics features of whole tumor were extracted from mean-kurtosis (MK), and
mean-diffusivity (MD) images, respectively (Figure 1). The ROIs
segmentation of the MRI images is showed in Figure 2. The multivariable
logistic regression was used to select the most meaningful radiomics features
for predicting IDH and MGMTmet genotypes. A radiomics model was built by
logistic linear regression. A combined model was established based on selected
radiomic, radiological and clinical features. To assess the
difference between the models, the Z-test was performed.Result
For
IDH prediction, the univariate analysis revealed that significant differences
existed in age (P = 0.001), grade (P = 0.004), edema degree (P < 0.001), and
enhancement degree (P = 0.002) between IDHMUT and IDHWT groups. By further
multivariable logistic regression analysis, the age and grade were selected to
develop clinical model with AUC = 0.775, the MK value and edema degree were
selected to develop radiological model with AUC = 0.810 (Figure 3A).
For
MGMTmet prediction, the univariate analysis showed that significant differences
existed in grade (P = 0.026), edema degree (P < 0.001), border (P = 0.047),
and enhancement degree (P = 0.035) between the MGMTmet and no MGMTmet groups.
The clinical model was built by grade (AUC = 0.671), the radiological model was
built by edema degree (AUC = 0.768) by further multivariate analysis (Figure
3B).
The
radiomics model built using the three most informative radiomics features for
each genotype yielded an AUC of 0.831 ((95% confidence interval [CI]:
0.721-0.918) for predicting IDH genotype, and 0.835 (95%CI: 0.686-0.951) for
MGMTmet genotype. A combined model for predicting IDH based on the radiomics
score, age, and degree of edema reached an AUC of 0.885 (95%CI: 0.802-0.955)
and a combined model for predicting MGMTmet based on radiomics score and edema
degree reached an AUC of 0.859 (95%CI: 0.751-0.945) which was not significantly
higher than the radiomics only model (P = 0.081) .Discussion and Conclusion
A radiomics models based on whole-tumor MK and
MD maps showed good diagnostic efficiency in predicting IDH and MGMTmet
genotypes of astrocytomas. Furthermore, the combined model constructed by
radiomics score, edema degree and age further improved the performance of
predicting IDH, while the combined model constructed by radiomics score and
edema degree did not benefit the predictive performance of MGMTmet.Acknowledgements
This
study was supported by the National Natural Science Foundation (81471652,
81771824 and 81971593 to Hui Zhang; 81701681 to Yan Tan; 81971592 to Xiao-chun
Wang; 11705112 to Guo-qiang Yang); the Precision Medicine Key Innovation Team
Project (YT1601 to Hui Zhang); the Social Development Projects of Key R&D
Program in Shanxi Province (201703D321016 to Hui Zhang); the Youth Innovation
Fund (YC1426 to Yan Tan); and the US National Cancer Institute, U01 CA143062
and U01CA200464 (Robert Gillies and Wei Mu).References
1. Raab
P, Hattingen E, Franz K, et al., Cerebral gliomas: diffusional kurtosis imaging
analysis of microstructural differences. Radiology. 2010;254(3):876-81.
2. Park
JE, Kim HS, Radiomics as a quantitative imaging biomarker: practical
considerations and the current standpoint in neuro-oncologic studies. Nuclear
Medicine and Molecular Imaging. 2018;52:99-108.
3. Lao
J, Chen Y, Li ZC, et al., A deep learning-based radiomics model for prediction
of survival in glioblastoma multiforme. Sci Rep. 2017;7(1):10353.
4. Gillies
RJ, Kinahan PE, Hricak H, Radiomics: Images are more than Pictures, they are
Data. Radiology. 2016;278:563-577.
5. Kleihues
P, Soylemezoglu F, Schauble B, et al., Histopathology, classification, and
grading of gliomas, Glia. 1995;15(3):211-221.